The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The Trump administration is planning a five-year test allowing states to cover weight-loss drugs like Ozempic and Wegovy ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so.

Cigna has sold its Medicare businesses and slashed the number of people it covers in its ACA plans by more than half.

The report, compiled for The New York Times by health analytics company Komodo Health, shows that denial rates rose from 18.3 ...

Full year 2025 pretax adjusted earnings outlooks for Evernorth and Cigna Healthcare remain at "at least $7.2 billion" and "at least $4.125 billion" respectively. The company expects the full year ...